Page last updated: 2024-09-05

tolvaptan and Cardiomyopathy, Congestive

tolvaptan has been researched along with Cardiomyopathy, Congestive in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inomata, T1

Reviews

2 review(s) available for tolvaptan and Cardiomyopathy, Congestive

ArticleYear
Tolvaptan (Samsca) for hyponatremia.
    The Medical letter on drugs and therapeutics, 2009, Nov-30, Volume: 51, Issue:1326

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Approval; Drug Interactions; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Tolvaptan; United States; United States Food and Drug Administration

2009
[Tolvaptan (vasopressin receptor antagonist)].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 9

    Topics: Benzazepines; Cardiomyopathy, Dilated; Diuretics; Heart Failure; Humans; Tolvaptan; Vasopressins

2011